Cynthia Lambert Hardman, a partner in Goodwin's IP Litigation group and chair of the firm’s PTAB practice, is a go-to patent litigator for complex patent cases in U.S. district courts, the U.S. International Trade Commission (ITC), and the U.S. Patent and Trademark Office Patent Trial and Appeal Board (PTAB).

Ms. Hardman represents clients in the pharmaceutical, biosimilar, medical device, nutritional supplement, and consumer product industries. She has deep experience in ANDA cases under the Hatch-Waxman Act and in inter partes reviews (IPRs), having appeared in over 30 pharma and biosimilars-related IPRs. She also litigates cases involving a wide range of other technologies and products such as spinal fixation devices, home pregnancy tests, and video content analysis systems and software.

Ms. Hardman's practice also extends to pre-litigation counseling, including rendering opinions on to patentability, infringement, validity and freedom-to-operate issues.

Ms. Hardman co-founded and co-authors Goodwin’s PTAB newsletter, The PTAB Trial Tracker, which analyzes PTAB, district court, and Federal Circuit decisions that impact post-grant review proceedings. Ms. Hardman is also an editor and regular contributor to the firm’s biosimilars blog, Big Molecule Watch. Ms. Hardman is also an active participant in the firm’s Cannabis practice.

Ms. Hardman has been cited by IAM Patent 1000 – The World’s Leading Patent Practitioners for her “sterling efforts” leading Goodwin’s PTAB practice.





Recent PTAB victories include:

  • Achieved victory for IPR petitioner on patent to a method of using an anti-cancer biologic. The decision helps clear our client's path to launching a biosimilar.
  • Achieved victory for patent owner in IPRs involving patents on a novel drug dosing regimen. The decisions help protect our client's innovative drug.
  • Achieved victory for IPR petitioner on patents to methods of using a nitrogen-scavenging drug. The decisions help clear our client's path to launching a generic drug.

Significant Hatch-Waxman and other litigation victories include:

  • Win following ANDA bench trial relating to an extended release ADHD suspension. The decision helps clear our client's path to launching its generic drug.
  • Represented a pharmaceutical company against a multi-billion dollar damages claim in a jury trial concerning an epilepsy drug.  Case settled during trial, resulting in a favorable settlement. 
  • Win following ANDA bench trial relating to an extended release treatment for overactive bladder. The Federal Circuit affirmed.
  • Represented a specialty supplements company concerning their krill oil products before the ITC, in a case that extended to the PTAB. A favorable settlement was reached.
  • Obtained a $5.7M award at summary judgment for a nutritional supplements company in a trademark and copyright counterfeiting case. 
  • Represented a patent licensee in a patent infringement suit concerning mobile video technology used by spectators at sporting events.
  • Represented a respondent in an ITC patent infringement trial concerning patents covering video analytics technology.
  • Represented a pharmaceutical company in an action involving patents for an extended release formulation of an antibiotic. Helped overturn a preliminary injunction, allowing client to market its generic equivalent of the drug.
Professional Activities

Ms. Hardman is an editor of the firm’s biosimilars-focused Big Molecule Watch blog, and a contributor to the firm’s Biosimilars Reference Guide and Guide to the Biosimilars Patent Dance.

She is a member of the Patent Trial and Appeal Board Bar Association.

Ms. Hardman’s recent pro bono work includes assisting students in obtaining special education services.

Professional Experience

Prior to joining Goodwin in 2014, Ms. Hardman was a partner at Kenyon & Kenyon LLP in New York City, where her practice focused on patent litigation and counseling matters.


Ms. Hardman is cited as a “Recommended” lawyer for post-grant proceedings by the IAM 1000 – The World's Leading Patent Practitioners and has been recognized as a “Rising Star” by Super Lawyers New York (2012-2014). In law school, she served as articles editor for the Journal of Science & Technology Law. In college, she received the Chancellor’s Undergraduate Research Award.

In The News









J.D., 2001
Boston University School of Law
B.S., Molecular Biology, 1996
University of Pittsburgh
(cum laude)



New York
U.S. Patent and Trademark Office (USPTO)


U.S. District Court for the Eastern District of New York
U.S. District Court for the Southern District of New York
U.S. Court of Appeals for the Federal Circuit
Get In Touch
German Translation
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique